Emerald Advisers and F/m Investments have launched the F/m Emerald Life Sciences Innovation ETF (LFSC) on the Nasdaq, targeting innovative small and mid-cap companies in the life sciences sector, including biotech and medical technology. The ETF utilizes a proprietary 10-Step Research Process to identify high-potential firms, aiming to capitalize on the rapid growth in healthcare driven by an aging population and increased demand for medical advancements. With U.S. healthcare spending projected to rise significantly, LFSC offers investors diversified exposure to transformative developments in the industry.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
